AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TETRACYCLINE HCL

9 registrations across 2 African markets— 3 active

Markets with TETRACYCLINE HCL

Recent registrations

Brand / ProductMarketHolderStatusExpires
Tetracycline capsules
Hard Gelatin Capsule
🇿🇲ZambiaKausikh Therapeutics Pvt LtdactiveJul 2030
Tetra 250 capsules
Capsules
🇿🇲ZambiaVIGOR LABORATORIESactiveMay 2029
Tetracycline Eye ointment
Ophthlamic ointment
🇿🇲ZambiaVIGOR LABORATORIESactiveMay 2029
RACYCLINE 1%W/W EYE OINTMENT
EYE OINTMENT
🇲🇼MalawiexpiredMar 2025
RACYCLINE_SKIN 3%W/W OINTMENT
OINTMENT
🇲🇼MalawiexpiredMar 2025
TETRACYCLINE 250MG CAPSULE
CAPSULE
🇲🇼MalawiexpiredMar 2023
TETRACYCLINE 1% EYE OINTMENT
EYE OINTMENT
🇲🇼MalawiexpiredJun 2017
TETRA-COL 250MG CAPSULE
CAPSULE
🇲🇼MalawiexpiredJun 2016
TETRACYCLINE 250MG CAPSULE
CAPSULE
🇲🇼MalawiexpiredJun 2013

TETRACYCLINE HCL in Africa — Regulatory Overview

TETRACYCLINE HCL is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 3 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.